Pfizer signs Agreement with US Government to Lower Drug Costs for American Patients
Pfizer has voluntarily agreed to implement measures designed to ensure Americans receive comparable drug prices to those available in other developed countries and pricing newly launched medicines at parity with other key developed markets.
Biopharmaceutical Innovation | 01/10/2025 | By Dineshwori
Eli Lilly has voiced opposition to proposed tariffs on pharmaceutical products, cautioning that such measures could increase costs, limit patient access, and weaken US leadership in biopharmaceutical innovation.
Biopharmaceutical Innovation | 16/08/2025 | By Dineshwori | 180
VectorBuilder Signs Deal with Sartorius to Advance Biopharmaceutical Innovation
The collaboration will focus on gene vector and mRNA bioprocess solutions and services, accelerating the development and clinical translation of innovative biopharmaceutical projects.
Biopharmaceutical Innovation | 29/11/2024 | By Aishwarya | 249
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy